Physiology of obesity and effects on lung function
Cheryl M Salome1, Gregory G King, Norbert Berend
1Woolcock Institute of Medical Research, P.O. Box M77, Missenden Rd. NSW 2050, Australia. cms@woolcock.org.au
Journal of Applied Physiology (Bethesda, Md. : 1985)
|October 31, 2009
Summary
Obesity reduces lung function by decreasing functional residual capacity (FRC), impacting breathing mechanics. This can worsen existing respiratory conditions and affect overall respiratory well-being.
Area of Science:
- Pulmonary Medicine
- Physiology
- Obesity Research
Background:
- Obesity, characterized by excess adipose tissue, significantly impacts chest wall mechanics.
- Increased visceral and abdominal fat can restrict chest wall expansion and reduce lung volumes.
Purpose of the Study:
- To investigate the multifaceted effects of obesity on lung function.
- To elucidate how reduced lung volumes in obesity influence gas exchange and respiratory mechanics.
Main Methods:
- Analysis of spirometry and lung volume measurements in obese individuals.
- Assessment of expiratory flow limitation and airway closure.
- Evaluation of ventilation-perfusion inequalities and arterial oxygen saturation.
Main Results:
- Obesity reduces functional residual capacity (FRC) and expiratory reserve volume.
- While direct airway caliber is minimally affected, reduced FRC increases risks of expiratory flow limitation and airway closure.
- Ventilation distribution abnormalities and V/Q inequalities can occur, potentially lowering arterial oxygen saturation.
Conclusions:
- Obesity impairs lung function by altering chest wall mechanics and reducing lung volumes.
- These changes can lead to respiratory complications and exacerbate pre-existing airway diseases.
- Reduced FRC is a key factor in the respiratory consequences of obesity.
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.